Cassiopea announces results of ordinary shareholders meeting
Cassiopea SpA, a clinical stage specialty pharmaceutical company focused on developing innovative and differentiated medical dermatology products, today announced the results of the shareholders meeting held on April 29, 2020 in Lainate.